MTAP and central nervous system cancer: The deficiency of MTAP has been reported in both solid tumors and hematologic malignancies, specifically glioma (2), leukemia (13, 14), non-small cell lung cancer (15), hepatocellular carcinoma (16), gastric carcinoma (17), and melanoma (18).